Clustering Identifies Subtypes With Different Phenotypic Characteristics in Women With Polycystic Ovary Syndrome.

IF 5 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Kim van der Ham, Loes M E Moolhuijsen, Kelly Brewer, Ryan Sisk, Andrea Dunaif, Joop S E Laven, Yvonne V Louwers, Jenny A Visser
{"title":"Clustering Identifies Subtypes With Different Phenotypic Characteristics in Women With Polycystic Ovary Syndrome.","authors":"Kim van der Ham, Loes M E Moolhuijsen, Kelly Brewer, Ryan Sisk, Andrea Dunaif, Joop S E Laven, Yvonne V Louwers, Jenny A Visser","doi":"10.1210/clinem/dgae298","DOIUrl":null,"url":null,"abstract":"<p><strong>Context: </strong>Hierarchical clustering (HC) identifies subtypes of polycystic ovary syndrome (PCOS).</p><p><strong>Objective: </strong>This work aimed to identify clinically significant subtypes in a PCOS cohort diagnosed with the Rotterdam criteria and to further characterize the distinct subtypes.</p><p><strong>Methods: </strong>Clustering was performed using the variables body mass index (BMI), luteinizing hormone (LH), follicle-stimulating hormone, dehydroepiandrosterone sulfate, sex hormone-binding globulin (SHBG), testosterone, insulin, and glucose. Subtype characterization was performed by analyzing the variables estradiol, androstenedione, dehydroepiandrosterone, cortisol, anti-Müllerian hormone (AMH), total follicle count (TFC), lipid profile, and blood pressure. Study participants were girls and women who attended our university hospital for reproductive endocrinology screening between February 1993 and February 2021. In total, 2502 female participants of European ancestry, aged 13 to 45 years with PCOS (according to the Rotterdam criteria), were included. A subset of these (n = 1067) fulfilled the National Institutes of Health criteria (ovulatory dysfunction and hyperandrogenism). Main outcome measures included the identification of distinct PCOS subtypes using cluster analysis. Additional clinical variables associated with these subtypes were assessed.</p><p><strong>Results: </strong>Metabolic, reproductive, and background PCOS subtypes were identified. In addition to high LH and SHBG levels, the reproductive subtype had the highest TFC and levels of AMH (all P < .001). In addition to high BMI and insulin levels, the metabolic subtype had higher low-density lipoprotein levels and higher systolic and diastolic blood pressure (all P < .001). The background subtype had lower androstenedione levels and features of the other 2 subtypes.</p><p><strong>Conclusion: </strong>Reproductive and metabolic traits not used for subtyping differed significantly in the subtypes. These findings suggest that the subtypes capture distinct PCOS causal pathways.</p>","PeriodicalId":50238,"journal":{"name":"Journal of Clinical Endocrinology & Metabolism","volume":" ","pages":"3096-3107"},"PeriodicalIF":5.0000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11570376/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Endocrinology & Metabolism","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1210/clinem/dgae298","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Context: Hierarchical clustering (HC) identifies subtypes of polycystic ovary syndrome (PCOS).

Objective: This work aimed to identify clinically significant subtypes in a PCOS cohort diagnosed with the Rotterdam criteria and to further characterize the distinct subtypes.

Methods: Clustering was performed using the variables body mass index (BMI), luteinizing hormone (LH), follicle-stimulating hormone, dehydroepiandrosterone sulfate, sex hormone-binding globulin (SHBG), testosterone, insulin, and glucose. Subtype characterization was performed by analyzing the variables estradiol, androstenedione, dehydroepiandrosterone, cortisol, anti-Müllerian hormone (AMH), total follicle count (TFC), lipid profile, and blood pressure. Study participants were girls and women who attended our university hospital for reproductive endocrinology screening between February 1993 and February 2021. In total, 2502 female participants of European ancestry, aged 13 to 45 years with PCOS (according to the Rotterdam criteria), were included. A subset of these (n = 1067) fulfilled the National Institutes of Health criteria (ovulatory dysfunction and hyperandrogenism). Main outcome measures included the identification of distinct PCOS subtypes using cluster analysis. Additional clinical variables associated with these subtypes were assessed.

Results: Metabolic, reproductive, and background PCOS subtypes were identified. In addition to high LH and SHBG levels, the reproductive subtype had the highest TFC and levels of AMH (all P < .001). In addition to high BMI and insulin levels, the metabolic subtype had higher low-density lipoprotein levels and higher systolic and diastolic blood pressure (all P < .001). The background subtype had lower androstenedione levels and features of the other 2 subtypes.

Conclusion: Reproductive and metabolic traits not used for subtyping differed significantly in the subtypes. These findings suggest that the subtypes capture distinct PCOS causal pathways.

聚类识别多囊卵巢综合征女性患者中具有不同表型特征的亚型。
背景层次聚类(HC)可识别多囊卵巢综合征(PCOS)的亚型:本研究旨在确定根据鹿特丹标准诊断的多囊卵巢综合征队列中具有临床意义的亚型,并进一步描述不同亚型的特征:方法:使用体重指数(BMI)、黄体生成素(LH)、卵泡刺激素、硫酸脱氢表雄酮、性激素结合球蛋白(SHBG)、睾酮、胰岛素和葡萄糖等变量进行聚类。通过分析雌二醇、雄烯二酮、脱氢表雄酮、皮质醇、抗穆勒氏管激素(AMH)、总卵泡数(TFC)、血脂和血压等变量来确定亚型特征。研究对象为 1993 年 2 月至 2021 年 2 月期间在我校医院接受生殖内分泌检查的女孩和妇女。共有 2502 名年龄在 13 至 45 岁之间、患有多囊卵巢综合症(根据鹿特丹标准)的欧洲血统女性参加了研究。其中一部分(n = 1067)符合美国国立卫生研究院的标准(排卵功能障碍和雄激素过多)。主要结果测量包括通过聚类分析确定不同的多囊卵巢综合症亚型。还评估了与这些亚型相关的其他临床变量:结果:确定了代谢、生殖和背景多囊卵巢综合症亚型。除 LH 和 SHBG 水平较高外,生殖亚型的 TFC 和 AMH 水平也最高(均 P < .001)。除了体重指数和胰岛素水平较高外,代谢亚型的低密度脂蛋白水平较高,收缩压和舒张压也较高(均 P < .001)。背景亚型的雄烯二酮水平较低,并具有其他两个亚型的特征:结论:未用于亚型划分的生殖和代谢特征在亚型中存在显著差异。这些发现表明,亚型捕捉到了不同的多囊卵巢综合症致病途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Endocrinology & Metabolism
Journal of Clinical Endocrinology & Metabolism 医学-内分泌学与代谢
CiteScore
11.40
自引率
5.20%
发文量
673
审稿时长
1 months
期刊介绍: The Journal of Clinical Endocrinology & Metabolism is the world"s leading peer-reviewed journal for endocrine clinical research and cutting edge clinical practice reviews. Each issue provides the latest in-depth coverage of new developments enhancing our understanding, diagnosis and treatment of endocrine and metabolic disorders. Regular features of special interest to endocrine consultants include clinical trials, clinical reviews, clinical practice guidelines, case seminars, and controversies in clinical endocrinology, as well as original reports of the most important advances in patient-oriented endocrine and metabolic research. According to the latest Thomson Reuters Journal Citation Report, JCE&M articles were cited 64,185 times in 2008.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信